Eli Lilly and Company (Lilly) recently announced a $4.5 billion (€4.07 billion) investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing...
South Korean contract development and manufacturing organization (CDMO) SK Pharmteco announced a major expansion of its small molecule and peptide production capabilities...
Last week, AbbVie broke ground on a new Singapore manufacturing facility located in Singapore's Tuas Biomedical Park. The company will invest $223 million in the site...
Successfully managing the drug substance manufacturing of Antibody-Drug Conjugates (ADCs) requires a sophisticated understanding of the technological development process...
19.09.2018
- Natural products have been used since thousands of years for the treatment of a wide range of medical conditions in the form of traditional medicines. Today 60% of all new small...
19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
09.06.2017
- US active pharmaceutical ingredients (API) manufacturer Cambrex Corporation has announced the expansion of large-scale manufacturing capacity at its cGMP plant in Karlskoga, Sweden...
